277 Pill - brown round, 10mm
Generic Name: sitagliptin
Pill with imprint 277 is Brown, Round and has been identified as Januvia 100 mg. It is supplied by Merck & Company Inc.
Januvia is used in the treatment of Diabetes, Type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 277






Januvia
- Generic Name
- sitagliptin
- Imprint
- 277
- Strength
- 100 mg
- Color
- Brown
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Company Inc.
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00006-0277 | Merck |
54569-5925 | A-S Medication Solutions, LLC (repackager) |
54868-5840 | Physicians Total Care Inc. (repackager) |
35356-0103 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
Related images for "277"
More about Januvia (sitagliptin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (138)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.